BackInterpace Biosciences Overview

Interpace Biosciences Receivables

Latest receivables for IDXG: $6.3M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$6.31M
↓ 12.72% YoYΔ $-920000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Interpace Biosciences Receivables History

Loading

Interpace Biosciences vs. peers: Receivables Comparison

Loading

Interpace Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Interpace Biosciences (IDXG) FAQ

Interpace Biosciences (IDXG) currently reports a receivables of $6.3M as of June 2026. That compares with $7.2M in the prior-year period — down 12.7% year over year. Use the charts on this page to explore Interpace Biosciences's receivables history and peer comparisons.

Interpace Biosciences's receivables decreased from $7.2M to $6.3M — a 12.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Interpace Biosciences reported $6.3M in receivables as of June 2026. That compares with $7.2M in the prior-year period — down 12.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $6.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Interpace Biosciences, and consider following IDXG for alerts when major investors trade the stock.